BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Aug 01, 2011
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Amylin, Eli Lilly sales and marketing update

Amylin reported in its 2Q11 earnings that partner Eli Lilly launched once-weekly Bydureon exenatide in the U.K. in July to treat Type II diabetes. The launch triggered a $15 million milestone payment to Amylin. The wholesale...

Read the full 167 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >